Modulation of Phospholipase A₂ Membrane Activity by Anti-inflammatory Drugs

Area of Science:

• Biochemistry
• Biophysics
• Pharmacology

Background:

• Phospholipase A2 (PLA2) enzymes hydrolyze cell membrane phospholipids, playing key roles in physiological processes.
• Dysregulated PLA2 activity is linked to inflammatory diseases, highlighting its therapeutic potential.
• Anti-inflammatory drugs (AIDs) are known PLA2 modulators, but their indirect effects on membrane structure are poorly understood.

Purpose of the Study:

• To investigate the indirect mechanisms by which AIDs modulate PLA2 activity through alterations in lipid membrane structure.
• To systematically study the structural properties of lipid membrane systems during PLA2 cleavage under the influence of various AIDs.

Main Methods:

• Differential scanning calorimetry (DSC) to analyze lipid membrane structural properties during PLA2 activity.
• Molecular dynamics (MD) simulations to provide atomistic details of AID-membrane interactions and dynamics.

Main Results:

• Thermodynamic data showed that AIDs reducing lipid membrane cooperativity hinder PLA2 cleavage.
• Conversely, other AIDs were observed to catalyze PLA2 activity to varying degrees.
• MD simulations revealed that AID efficacy in impacting membrane cooperativity correlates with lipid order perturbation.

Conclusions:

• A membrane-based mechanism of action for AIDs targeting PLA2 activity is proposed.
• The study provides crucial insights into how AIDs interact with lipid membranes to modulate PLA2 function.
• Findings suggest that considering membrane structural changes is essential for developing effective PLA2 modulators.